Skip to content
Monday, November 9, 2026
Discover the best gaming arenas across the UK. ArenaBase pr…

Individuals Stopping Weight-Loss Injections Put On Weight Four Times Faster Than Those on Conventional Diets

Image of medical syringe and scale
Weight management involves long-term strategies.

Fresh analysis indicates that individuals who discontinue new slimming jabs like semaglutide or tirzepatide may regain lost weight far faster than those who end traditional diet and exercise programs.

Published data in a prominent medical journal demonstrates that while overweight individuals often shed about a fifth of their total mass while on the medication, the mass returns at an estimated rate of 0.8 kg per month after stopping.

"People purchasing these medications should be aware of the potential of quick rebound weight gain when the therapy concludes," cautioned expert Dr. Susan Jebb.

Such speed of regain implies a reversion to original weight within about a year and a half.

Weighing Treatments

The analysis, which looked at dozens of trials involving thousands of participants, contrasted the results of these new drugs with older methods.

Scientists emphasize that individuals who lose weight through diet and exercise usually have a slower creep back—around 100 grams monthly—after stopping.

The Reason for the Fast Rebound

Doctors believe the mode of action of the jabs accounts for the amplified regain.

GLP-1 drugs imitate a natural hormone called GLP-1, which controls appetite.

"Sustained high doses of GLP-1 concentrations far above than normal might result in the system to produce less of its own natural hormone, and may also lessen sensitivity to its actions," noted Dr. Adam Collins, a dietetics specialist.

"Stopping of this GLP-1 'fix' leads to hunger is unsuppressed, making overeating far more likely."

A Chronic Issue?

Medical guidelines recommend the jabs for individuals with weight-linked health risks, alongside recommended diet and exercise modifications.

A number of clinicians say that, given the likelihood of relapse, the treatment is often life-long.

This perspective is supported by drug manufacturers, who state that the findings "underscore the long-term character of excess weight," similar to managing diseases like hypertension.

User Accounts

Individuals who have stopped the medication report a sudden return of cravings.

"It felt as if something that goes on and I was suddenly starving," recalled one woman.

This difficulty is exacerbated if users have not developed sustainable dietary or behavioural changes during therapy.

Significant Adoption

Figures indicate that a significant number of people in the UK have tried weight-loss jabs in the past year, with desire being substantial.

  • Use is greater among women than men.
  • The 40s and 50s demographic shows the greatest level of interest.
  • Many access the medications through private prescriptions rather than public health services.

Ultimately, clinicians stress that while these medications are powerful agents for weight loss, they are not a permanent fix and lasting health benefits likely depends on integrated behavioural changes.

MA
The writer

Matthew Alvarado

Alex is a professional esports journalist and avid gamer who travels across the UK covering competitive gaming events and arena reviews.

ArenaBase UK

Type to search articles.